| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8454518 | Lung Cancer | 2016 | 7 Pages |
Abstract
Mesothelin expression is frequently observed in advanced thymic carcinomas, infrequently in thymomas and is absent in thymic NETs. Due to strong, membranous expression mesothelin is a potential therapeutic target in thymic carcinoma.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Anish MD, Yuanbin MD PhD, Arlene MS, David S. MD, Giuseppe MD PhD, Ira MD, David J. PhD, David J. MS, Seth M. PhD, Markku MD, Raffit MD, Arun MD,